Dr. John Moppett studied medicine at Jesus College Cambridge and St. Bartholomew’s Hospital London. He trained in both Paediatric Oncology and Haematology in the UK, Australia and Canada, and obtained his PhD in 2003 from the University of Bristol. He was appointed to his current role of consultant Paediatric Haematologist at Bristol Royal Hospital for Children in 2007. His clinical practice covers Paediatric Malignant Haematology and Benign Haematology

He studied Measurable Residual Disease for ALL for hi PhD at the University of Bristol and is now the Clinical Lead for the UK Childhood ALL Molecular and Flow MRD laboratory networks. His research interests are Measurable Residual Disease and clinical trials in Childhood Acute Lymphoblastic Leukaemia (ALL). He is clinical lead for the current de novo Childhood ALL study, ALLtogether1.  In these roles he has been heavily involved in the development of the molecular aspects of treatment of ALL.